Reports from Moderna Inc. Add New Data to Findings in COVID-19 (Real-world Comparative Effectiveness of a Third Dose of Mrna-1273 Versus Bnt162b2 Among Adults Aged 65 Years In the United States)

Source :: Medical Letter on the CDC & FDA. November 24, 2024, 240
Publication Year :: 2024
Abstract: 2024 NOV 24 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- New research on Coronavirus - COVID-19 is the subject of [...]

Subjects :: Comirnaty (Vaccine) -- Comparative analysis -- Research
Spikevax (Vaccine) -- Comparative analysis -- Research
Research
Comparative analysis
Vaccines -- Research
Coronaviruses -- Research -- Comparative analysis
Medical research -- Comparative analysis
COVID-19 -- Research
Messenger RNA -- Comparative analysis -- Research
Adults -- Research -- Comparative analysis
Medicine, Experimental -- Comparative analysis

Tools